EDIT vs EVRG · rev $32.3M vs P/E 22, rev $5.85B
Editas Medicine Inc (EDIT) versus Evergy, Inc. (EVRG) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported EVRG revenue for 2024-12-31 was $5.85B. Net income was $885.8M. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
EDIT currently screens at market cap $375.2M. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Not investment advice. Open the EDIT and EVRG stock pages for the full models.
Not investment advice.